Triple-negative breast cancer: making the most of a misnomer.
about
Combined phosphoproteomics and bioinformatics strategy in deciphering drug resistant related pathways in triple negative breast cancer.Myeloid cell leukemia-1 is an important apoptotic survival factor in triple-negative breast cancer.siRNA-mediated suppression of collagen type iv alpha 2 (COL4A2) mRNA inhibits triple-negative breast cancer cell proliferation and migration.Enhancing the antitumor activity of berberine hydrochloride by solid lipid nanoparticle encapsulation
P2860
Triple-negative breast cancer: making the most of a misnomer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Triple-negative breast cancer: making the most of a misnomer.
@en
type
label
Triple-negative breast cancer: making the most of a misnomer.
@en
prefLabel
Triple-negative breast cancer: making the most of a misnomer.
@en
P2093
P2860
P1476
Triple-negative breast cancer: making the most of a misnomer.
@en
P2093
Geoffrey J Lindeman
Gillian Mitchell
Michael Bilous
Nicholas Wilcken
Nicole McCarthy
P2860
P304
P356
10.1111/J.1743-7563.2012.01533.X
P577
2012-06-01T00:00:00Z